04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
The coronavirus disease (COVID-19) continues to dominate global headlines and markets. In the U.S., ...
Read More >
On December 20, 2019 the Taxpayer Certainty and Disaster Tax Relief Act of 2019 (2019 Disaster Act) ...
Read More >
PilieroMazza Wins HUBZone Small Business Resource Partner of the Year! The HUBZone Contractors Nati...
Read More >
Recreational cannabis is poised to become legal in Illinois in 2020, and Illinois employers should c...
Read More >
On September 24, 2019, the U.S. Department of Labor announced the Final Overtime Rule which will go ...
Read More >
Over the past weeks, I’ve written a few times on the ongoing requirements and changing deadlines of...
Read More >